A Mock Simulation of A Remote/Decentralised Clinical Trial for Patients with Major Depressive Disorder in Japan

A Mock Simulation of A Remote/Decentralised Clinical Trial for Patients with Major Depressive Disorder in Japan - A Remote/Decentralised Clinical Trial Mock Simulation for Patients with Depression

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048873

Enrollment

Registered

2022-10-01

Start date

2022-12-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patient: 1) A patient with a diagnosis of major depressive disorder (according to the diagnostic criteria defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) 2) A patient whose major depressive disorder is mild or in remission 3) A patient aged >=18 years Investigator: 1) A physician with experience of a principal investigator conducting pharmaceutical company-sponsored clinical trials in patients with a psychiatric disorder 2) A physician with high interest in the conduct of remote/decentralised clinical trials (both as self-reported) Person with experience of clinical research coordinator: 1) A person with experience of clinical research coordinator in a pharmaceutical company-sponsored clinical trial in patients with a psychiatric disorder 2) A person with high interest in the conduct of remote/decentralised clinical trials (both as self-reported)

Exclusion criteria

Exclusion criteria: Exclusion criteria: Patient: 1) A patient not capable of providing consent to participate in this study or being interviewed at physician's discretion

Design outcomes

Primary

Measure	Time frame
Patient demographics, feedback on the clinical trial plan	—

Countries

Japan

Contacts

Public ContactNobutaka Yagi

Nippon Boehringer Ingelheim Co., Ltd. Patient Engagement

nobutaka.yagi@boehringer-ingelheim.com0364172043

Outcome results